Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors (Q46630294)
Jump to navigation
Jump to search
scientific article published in August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors |
scientific article published in August 2005 |
Statements
1 reference
Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors (English)
1 reference
Heinz-Josef Lenz
1 reference
Jeffrey W Clark
1 reference
Joseph P Eder
1 reference
David Ryan
1 reference
Chetan Lathia
1 reference
1 August 2005
1 reference
1 reference
11
1 reference
15
1 reference
5472-5480
1 reference
Identifiers
1 reference
1 reference